Skip to content

Curcumin-piperine changed blood tests in intensive-care sepsis patients

Compared with placebo, curcumin-piperine changed several laboratory measurements in critically ill patients with sepsis. The abstract does not establish whether those changes translated into improved survival or recovery.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

In critically ill patients with sepsis, curcumin-piperine produced statistically significant changes in several blood measurements compared with placebo. These included a lower inflammation marker, but the clinical meaning of the overall pattern remains uncertain. Deaths occurred in both groups, and the abstract provides no statistical assessment showing whether survival differed.

Keep in mind

The abstract reports statistical significance without the sizes of laboratory changes. It does not provide a mortality comparison with uncertainty estimates, so the death counts alone cannot establish a survival effect.

THE RESULT, WITH CONTEXT

What researchers found

Lower C-reactive protein

Blood marker of inflammation

Curcumin-piperine versus placebo after 7 days; statistically significant reduction reported, without a change magnitude.

Trials, 2025 · Original source ↓

Blood tests versus recovery

The trial assessed laboratory measurements before and after supplementation. Several changed in different directions, including platelet count and blood acidity. A statistically significant laboratory change does not by itself show that patients recovered better.

What the deaths show

The abstract reports 10 deaths in the supplement group and 12 in the placebo group. Without a reported statistical comparison or mortality follow-up period, those counts leave the treatment's effect on survival unresolved.

CHECK THE ORIGINAL

The original publication

Therapeutic effects of curcumin and piperine combination in critically ill patients with sepsis: a randomized double-blind controlled trial.

Alikiaii B, Khatib N, Badpeyma M et al.
Trials · 2025

PubMed ID
40514680
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.